Total Payments
$9,682
2024 Payments
$1,313
Companies
47
Transactions
507
Medicare Patients
1,860
Medicare Billing
$158,137
Payment Breakdown by Category
Food & Beverage$9,661 (99.8%)
Education$18.51 (0.2%)
Travel$2.57 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,661 | 504 | 99.8% |
| Education | $18.51 | 2 | 0.2% |
| Travel and Lodging | $2.57 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,085 | 63 | $0 (2024) |
| Novo Nordisk Inc | $915.13 | 48 | $0 (2024) |
| Lilly USA, LLC | $895.17 | 57 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $752.18 | 43 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $709.35 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $600.67 | 32 | $0 (2022) |
| Corcept Therapeutics | $569.89 | 26 | $0 (2024) |
| ABBVIE INC. | $458.43 | 30 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $349.55 | 20 | $0 (2024) |
| Dexcom, Inc. | $322.95 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,313 | 49 | Lilly USA, LLC ($261.65) |
| 2023 | $1,882 | 116 | Corcept Therapeutics ($363.69) |
| 2022 | $2,817 | 144 | SANOFI-AVENTIS U.S. LLC ($420.16) |
| 2021 | $3,671 | 198 | AstraZeneca Pharmaceuticals LP ($555.07) |
All Payment Transactions
507 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $58.17 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/19/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $61.92 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/27/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Endocrinology | ||||||
| 08/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $120.59 | General |
| 07/18/2024 | Lilly USA, LLC | — | Travel and Lodging | Cash or cash equivalent | $2.57 | General |
| 07/15/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Hyperthyroidism | ||||||
| 07/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $148.52 | General |
| Category: Diabetes Care | ||||||
| 06/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/04/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $95.49 | General |
| Category: DIABETES | ||||||
| 05/20/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Insulin Pump | ||||||
| 05/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Gastroenterology | ||||||
| 04/29/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $14.06 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 655 | 1,182 | $202,092 | $52,190 |
| 2022 | 11 | 568 | 1,059 | $196,827 | $50,267 |
| 2021 | 9 | 566 | 983 | $167,485 | $50,567 |
| 2020 | 3 | 71 | 77 | $15,675 | $5,113 |
Total Patients
1,860
Total Services
3,301
Medicare Billing
$158,137
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 519 | $129,750 | $37,123 | 28.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 75 | 153 | $16,065 | $3,297 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 29 | $10,005 | $3,052 | 30.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 129 | 267 | $13,884 | $2,542 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,825 | $1,727 | 25.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 34 | 36 | $13,680 | $1,686 | 12.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,975 | $681.24 | 22.9% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 12 | 13 | $1,222 | $355.94 | 29.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 12 | 13 | $1,209 | $328.77 | 27.2% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 11 | 12 | $900.00 | $255.60 | 28.4% |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | Office | 2023 | 12 | 13 | $1,144 | $236.73 | 20.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 12 | 12 | $780.00 | $199.20 | 25.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 12 | 12 | $948.00 | $197.52 | 20.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 26 | 27 | $783.00 | $164.97 | 21.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 13 | 14 | $770.00 | $144.90 | 18.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 12 | $672.00 | $106.08 | 15.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 12 | $480.00 | $91.32 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 518 | $129,500 | $37,358 | 28.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 67 | 155 | $16,275 | $3,236 | 19.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 52 | 52 | $19,760 | $2,359 | 11.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 22 | $7,590 | $2,322 | 30.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 116 | 223 | $11,596 | $2,108 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $4,900 | $1,412 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,550 | $960.70 | 21.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 12 | 12 | $948.00 | $181.06 | 19.1% |
About Phong Dang, PA
Phong Dang, PA is a Physician Assistant healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2020. The National Provider Identifier (NPI) number assigned to this provider is 1346853074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Phong Dang, PA has received a total of $9,682 in payments from pharmaceutical and medical device companies, with $1,313 received in 2024. These payments were reported across 507 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,661).
As a Medicare-enrolled provider, Dang has provided services to 1,860 Medicare beneficiaries, totaling 3,301 services with total Medicare billing of $158,137. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Oklahoma City, OK
- Active Since 08/24/2020
- Last Updated 08/24/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1346853074
Products in Payments
- JARDIANCE (Drug) $1,249
- Kerendia (Drug) $699.05
- FARXIGA (Drug) $600.67
- SOLIQUA 100/33 (Biological) $594.13
- Korlym (Drug) $569.89
- Rybelsus (Drug) $347.82
- RECORLEV (Drug) $286.19
- FREESTYLE LIBRE 3 (Device) $280.21
- AFREZZA (Drug) $279.01
- Ozempic (Drug) $264.12
- INJECTAFER (Drug) $225.26
- Dexcom G6 Transmitter (Medical Supply) $222.29
- BAQSIMI (Drug) $210.11
- Wegovy (Drug) $188.20
- TRULICITY (Drug) $158.21
- OVA1 (Device) $149.46
- LICART (Drug) $138.56
- ZEGALOGUE (Drug) $128.07
- CeQur Simplicity (Device) $127.18
- Prolia (Biological) $118.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Oklahoma City
Jennifer Smith, Pa, PA
Physician Assistant — Payments: $74,736
Physician Assistant $74,736
Sarah Hawk, Pa, PA
Physician Assistant — Payments: $21,842
Physician Assistant $21,842
Gavin Christie, Pa, PA
Physician Assistant — Payments: $18,388
Physician Assistant $18,388
Brett Horst, Pa, PA
Physician Assistant — Payments: $13,890
Physician Assistant $13,890
Ms. Mary Jane Rorick, Pa-C, PA-C
Physician Assistant — Payments: $13,494
Physician Assistant $13,494
Jovonne Smith, Pa, PA
Physician Assistant — Payments: $11,871
Physician Assistant $11,871